Vivos Therapeutics, Inc. conducted its 2023 annual meeting of stockholders, where they approved an amendment to the 2019 Stock Option and Stock Issuance Plan, elected directors, ratified the appointment of an independent registered public accounting firm, and approved a reverse stock split.